Zalcitabine and didanosine.
Lipsky
J J
JJ
Department of Medicine, Mayo Clinic, Rochester, MN 55905.
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D002648:Child; D004261:DNA Replication / Q000187:drug effects*; D004279:DNA, Viral / Q000187:drug effects; D016049:Didanosine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D004347:Drug Interactions; D006678:HIV / Q000187:drug effects / Q000502:physiology; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D014779:Virus Replication / Q000187:drug effects*; D016047:Zalcitabine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*
D000998:Antiviral Agents; D004279:DNA, Viral; D016047:Zalcitabine; D016049:Didanosine